Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Risberg

Showing results (281-290 of 290) with videos related to

Pageof 29
Sort By:
You have reached the last page of results.This site can display upto 290 results.
Cytopathology : Official Journal of the British Society for Clinical Cytology|October 29, 2011
Flow cytometric measurement of cellular FLICE-inhibitory protein (c-FLIP) in ovarian carcinoma effusionsH P Dong, A K Ree Rosnes, A J Bock, et al.
The Journal of Pathology|December 13, 2000
E-cadherin and alpha-, beta-, and gamma-catenin protein expression is up-regulated in ovarian carcinoma cells in serous effusionsB Davidson, A Berner, J M Nesland, et al.
Cardiovascular Surgery (London, England)|August 1, 1997
Bifurcated stent-graft for abdominal aortic aneurysmT A Chuter, G Wendt, B R Hopkinson, et al.
Oncogene|August 8, 2012
Flotillins as regulators of ErbB2 levels in breast cancerS Pust, T I Klokk, N Musa, et al.
Cancer Research|February 1, 1997
The reciprocal translocation t(9;16)(q22;p13) is a primary chromosome abnormality in basal cell carcinomasY Jin, F Merterns, B Persson, et al.
Cancer Genetics and Cytogenetics|May 22, 1998
Nonrandom numerical chromosome abnormalities in basal cell carcinomasY Jin, F Mertens, B Persson, et al.
Gynecologic Oncology|October 19, 2001
Expression of cell cycle proteins in ovarian carcinoma cells in serous effusions-biological and prognostic implicationsB Davidson, B Risberg, A Berner, et al.
European Journal of Cancer (Oxford, England : 1990)|October 13, 2001
Ovarian carcinoma cells in serous effusions show altered MMP-2 and TIMP-2 mRNA levelsB Davidson, R Reich, A Berner, et al.
American Journal of Clinical Pathology|April 11, 2001
Expression of membrane-type 1, 2, and 3 matrix metalloproteinases messenger RNA in ovarian carcinoma cells in serous effusionsB Davidson, I Goldberg, A Berner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2001
Expression levels of the nerve growth factor receptors TrkA and p75 in effusions and solid tumors of serous ovarian carcinoma patientsB Davidson, P Lazarovici, A Ezersky, et al.
Pageof 29

Showing results (281-290 of 290) with videos related to

Sort By:
Pageof 29
You have reached the last page of results.This site can display upto 290 results.
Cytopathology : Official Journal of the British Society for Clinical Cytology|October 29, 2011
Flow cytometric measurement of cellular FLICE-inhibitory protein (c-FLIP) in ovarian carcinoma effusionsH P Dong, A K Ree Rosnes, A J Bock, et al.
The Journal of Pathology|December 13, 2000
E-cadherin and alpha-, beta-, and gamma-catenin protein expression is up-regulated in ovarian carcinoma cells in serous effusionsB Davidson, A Berner, J M Nesland, et al.
Cardiovascular Surgery (London, England)|August 1, 1997
Bifurcated stent-graft for abdominal aortic aneurysmT A Chuter, G Wendt, B R Hopkinson, et al.
Oncogene|August 8, 2012
Flotillins as regulators of ErbB2 levels in breast cancerS Pust, T I Klokk, N Musa, et al.
Cancer Research|February 1, 1997
The reciprocal translocation t(9;16)(q22;p13) is a primary chromosome abnormality in basal cell carcinomasY Jin, F Merterns, B Persson, et al.
Cancer Genetics and Cytogenetics|May 22, 1998
Nonrandom numerical chromosome abnormalities in basal cell carcinomasY Jin, F Mertens, B Persson, et al.
Gynecologic Oncology|October 19, 2001
Expression of cell cycle proteins in ovarian carcinoma cells in serous effusions-biological and prognostic implicationsB Davidson, B Risberg, A Berner, et al.
European Journal of Cancer (Oxford, England : 1990)|October 13, 2001
Ovarian carcinoma cells in serous effusions show altered MMP-2 and TIMP-2 mRNA levelsB Davidson, R Reich, A Berner, et al.
American Journal of Clinical Pathology|April 11, 2001
Expression of membrane-type 1, 2, and 3 matrix metalloproteinases messenger RNA in ovarian carcinoma cells in serous effusionsB Davidson, I Goldberg, A Berner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2001
Expression levels of the nerve growth factor receptors TrkA and p75 in effusions and solid tumors of serous ovarian carcinoma patientsB Davidson, P Lazarovici, A Ezersky, et al.
Pageof 29